Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
The Food and Drug Administration OK'd 10 Zyn flavors, including coffee, mint and menthol. It's the first time regulators have authorized sales of nicotine pouches, which are the fastest-growing segment of the U.S. tobacco market.
On January 16, Philip Morris International Inc. (NYSE:PM) announced that the US Food and Drug Administration (FDA) has authorized all ZYN nicotine pouches currently marketed by Swedish Match.
MEAG Munich Ergo, a Munich Re company, slashed stakes in Philip Morris, Apple, and PayPal, and bought Lululemon stock in the fourth quarter.
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40 ...
The US Food and Drug Administration has today authorised Swedish Match’s ZYN nicotine pouches, marking a milestone for the Philip Morris International subsidiary.